TY - JOUR
T1 - Novel Clinical Therapies and Technologies in Dialysis Vascular Access
AU - Takahashi, Edwin A.
AU - Kilari, Sreenivasulu
AU - Misra, Sanjay
N1 - Publisher Copyright:
© 2021 by the American Society of Nephrology.
PY - 2021/8/1
Y1 - 2021/8/1
N2 - The hemodialysis population continues to grow. Although procedures for dialysis have existed for >60 years, significant challenges with vascular access to support hemodialysis persist. Failure of arteriovenous fistulas (AVFs) to mature, loss of AVF and graft patency, thrombosis, and infection hinder long-term access, and add extra health care costs and patient morbidity. There have been numerous innovations over the last decade aimed at addressing the issues. In this study, we review the literature and summarize the recent evolution of drug delivery, graft development, minimally invasive AVF creation, and stem-cell therapy for hemodialysis access.
AB - The hemodialysis population continues to grow. Although procedures for dialysis have existed for >60 years, significant challenges with vascular access to support hemodialysis persist. Failure of arteriovenous fistulas (AVFs) to mature, loss of AVF and graft patency, thrombosis, and infection hinder long-term access, and add extra health care costs and patient morbidity. There have been numerous innovations over the last decade aimed at addressing the issues. In this study, we review the literature and summarize the recent evolution of drug delivery, graft development, minimally invasive AVF creation, and stem-cell therapy for hemodialysis access.
KW - arteriovenous fistula
KW - chronic kidney disease
KW - dialysis
KW - drug delivery
KW - stenosis
UR - http://www.scopus.com/inward/record.url?scp=85141828004&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141828004&partnerID=8YFLogxK
U2 - 10.34067/KID.0002962021
DO - 10.34067/KID.0002962021
M3 - Review article
AN - SCOPUS:85141828004
SN - 2641-7650
VL - 2
SP - 1373
EP - 1379
JO - Kidney360
JF - Kidney360
IS - 8
ER -